NCT05025800Clin Cancer ResevorpaceptlenalidomiderituximabB-cell non-hodgkin lymphomaB-NHLALX148
…checkpoint inhibitor.Methods In this single-arm phase 1 trial ( NCT05025800), adult patients with relapsed indolent B-NHL received evorpace…
Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
This institution is selected. Its supporting articles are shown below.
…checkpoint inhibitor.Methods In this single-arm phase 1 trial ( NCT05025800), adult patients with relapsed indolent B-NHL received evorpace…